Ensi, Mel A.
HRN: 21-82-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
MEBENDAZOLE 50MG/ML, 60ML SUSPENSION (BOT)
08/25/2022
08/27/2022
PO
5ml
BID
Ascariasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes